Oncogenes and Tumor Suppressors|
November 16, 2008
Evi-1 Is a Direct Target of MLL Oncoproteins in Hematopoietic Stem Cells
Shunya Arai,
Shunya Arai
*
1Hematology and Oncology, University of Tokyo, Tokyo, Japan
Search for other works by this author on:
Susumu Goyama,
Susumu Goyama
*
1Hematology and Oncology, University of Tokyo, Tokyo, Japan
Search for other works by this author on:
Munetake Shimabe,
Munetake Shimabe
*
2Hematology and Oncology, Graduate School of Med., Tokyo, Japan
Search for other works by this author on:
Motoshi Ichikawa,
Motoshi Ichikawa
*
1Hematology and Oncology, University of Tokyo, Tokyo, Japan
Search for other works by this author on:
Yoichi Imai,
Yoichi Imai
*
1Hematology and Oncology, University of Tokyo, Tokyo, Japan
Search for other works by this author on:
Tsuyoshi Takahashi,
Tsuyoshi Takahashi
*
1Hematology and Oncology, University of Tokyo, Tokyo, Japan
Search for other works by this author on:
Akira Hangaishi,
Akira Hangaishi
*
1Hematology and Oncology, University of Tokyo, Tokyo, Japan
Search for other works by this author on:
Mineo Kurokawa, MD, PhD
Mineo Kurokawa, MD, PhD
2Hematology and Oncology, Graduate School of Med., Tokyo, Japan
Search for other works by this author on:
Blood (2008) 112 (11): 3807.
Citation
Shunya Arai, Susumu Goyama, Munetake Shimabe, Motoshi Ichikawa, Yoichi Imai, Tsuyoshi Takahashi, Akira Hangaishi, Mineo Kurokawa; Evi-1 Is a Direct Target of MLL Oncoproteins in Hematopoietic Stem Cells. Blood 2008; 112 (11): 3807. doi: https://doi.org/10.1182/blood.V112.11.3807.3807
Download citation file:
